glp 1 receptor agonist moa GLP1 Agonists—Effects beyond Obesity and Diabetes GLP1 - Mechanism of Action

Different Classes of Beta-Blockers and Specific Drugs Beta-blockers that are used clinically can be divided into two classes: 1) non-selective blockers (block both 1 and 2 receptors) , or 2) relatively selective 1 blockers ("cardioselective" beta-blockers)

10.1039/B417639C Nat

For instance, the activation of sterol regulatory element-binding proteins (SREBPs) drives the upregulation of key metabolic enzymes (e.g., ACLY, FASN, and HMGCR) [8,9,10], enabling tumor cells to coopt de novo lipogenesis and cholesterol synthesis, which secures the supply of structural building blocks required to sustain tumor expansion

A balanced approach helps maintain consistent results

W.LadensteinR.SchfferJ.GallayO.HuberR